Pregabalin Zentiva

Nchi: Umoja wa Ulaya

Lugha: Kiingereza

Chanzo: EMA (European Medicines Agency)

Nunua Sasa

Taarifa za kipeperushi Taarifa za kipeperushi (PIL)
19-03-2024
Tabia za bidhaa Tabia za bidhaa (SPC)
19-03-2024

Viambatanisho vya kazi:

pregabalin

Inapatikana kutoka:

Zentiva, k.s.

ATC kanuni:

N03AX16

INN (Jina la Kimataifa):

pregabalin

Kundi la matibabu:

Antiepileptics,

Eneo la matibabu:

Anxiety Disorders; Epilepsy

Matibabu dalili:

Neuropathic pain , Pregabalin Zentiva is indicated for the treatment of peripheral and central neuropathic pain in adults. , Epilepsy , Pregabalin Zentiva is indicated as adjunctive therapy in adults with partial seizures with or without secondary generalisation. , Generalised anxiety disorder , Pregabalin Zentiva is indicated for the treatment of generalised anxiety disorder (GAD) in adults.

Bidhaa muhtasari:

Revision: 15

Idhini hali ya:

Authorised

Idhini ya tarehe:

2015-07-17

Taarifa za kipeperushi

                                58
B. PACKAGE LEAFLET
59
PACKAGE LEAFLET: INFORMATION FOR THE USER
PREGABALIN ZENTIVA 25 MG HARD CAPSULES
PREGABALIN ZENTIVA 50 MG HARD CAPSULES
PREGABALIN ZENTIVA 75 MG HARD CAPSULES
PREGABALIN ZENTIVA 100 MG HARD CAPSULES
PREGABALIN ZENTIVA 150 MG HARD CAPSULES
PREGABALIN ZENTIVA 200 MG HARD CAPSULES
PREGABALIN ZENTIVA 225 MG HARD CAPSULES
PREGABALIN ZENTIVA 300 MG HARD CAPSULES
pregabalin
READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS
MEDICINE BECAUSE IT CONTAINS
IMPORTANT INFORMATION FOR YOU.
-
Keep this leaflet. You may need to read it again.
-
If you have any further questions, ask your doctor or pharmacist.
-
This medicine has been prescribed for you only. Do not pass it on to
others. It may harm them,
even if their signs of illness are the same as yours.
-
If you get any side effects, talk to your doctor or pharmacist. This
includes any possible side
effects not listed in this leaflet. See section 4.
WHAT IS IN THIS LEAFLET
1.
What Pregabalin Zentiva is and what it is used for
2.
What you need to know before you take Pregabalin Zentiva
3.
How to take Pregabalin Zentiva
4.
Possible side effects
5.
How to store Pregabalin Zentiva
6.
Contents of the pack and other information
1.
WHAT PREGABALIN ZENTIVA IS AND WHAT IT IS USED FOR
Pregabalin Zentiva belongs to a group of medicines used to treat
epilepsy, neuropathic pain
and generalised anxiety disorder (GAD) in adults.
PERIPHERAL AND CENTRAL NEUROPATHIC PAIN
Pregabalin Zentiva is used to treat long lasting pain caused by damage
to the nerves. A variety
of diseases can cause peripheral neuropathic pain, such as diabetes or
shingles. Pain sensations may
be described as hot, burning, throbbing, shooting, stabbing, sharp,
cramping, aching, tingling,
numbness, pins and needles. Peripheral and central neuropathic pain
may also be associated with
mood changes, sleep disturbance, fatigue (tiredness), and can have an
impact on physical and social
functioning and overall quality of life.
EPILEPSY
Pregabalin Zentiva is used to treat a certain form of ep
                                
                                Soma hati kamili
                                
                            

Tabia za bidhaa

                                1
ANNEX I
SUMMARY OF PRODUCT CHARACTERISTICS
2
1.
NAME OF THE MEDICINAL PRODUCT
Pregabalin Zentiva 25 mg hard capsules
Pregabalin Zentiva 50 mg hard capsules
Pregabalin Zentiva 75 mg hard capsules
Pregabalin Zentiva 100 mg hard capsules
Pregabalin Zentiva 150 mg hard capsules
Pregabalin Zentiva 200 mg hard capsules
Pregabalin Zentiva 225 mg hard capsules
Pregabalin Zentiva 300 mg hard capsules
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Pregabalin Zentiva 25 mg hard capsules
Each hard capsule contains 25 mg of pregabalin.
Excipient with known effect
Each hard capsule also contains 47.57 mg lactose monohydrate.
Pregabalin Zentiva 50 mg hard capsules
Each hard capsule contains 50 mg of pregabalin.
Excipient with known effect
Each hard capsule also contains 5 mg lactose monohydrate.
Pregabalin Zentiva 75 mg hard capsules
Each hard capsule contains 75 mg of pregabalin.
Excipient with known effect
Each hard capsule also contains 7.5 mg lactose monohydrate.
Pregabalin Zentiva 100 mg hard capsules
Each hard capsule contains 100 mg of pregabalin.
Excipient with known effect
Each hard capsule also contains 10 mg lactose monohydrate.
Pregabalin Zentiva 150 mg hard capsules
Each hard capsule contains 150 mg of pregabalin.
Excipient with known effect
Each hard capsule also contains 15 mg lactose monohydrate.
Pregabalin Zentiva 200 mg hard capsules
Each hard capsule contains 200 mg of pregabalin.
Excipient with known effect
Each hard capsule also contains 20 mg lactose monohydrate.
Pregabalin Zentiva 225 mg hard capsules
Each hard capsule contains 225 mg of pregabalin.
3
Excipient with known effect
Each hard capsule also contains 22.5 mg lactose monohydrate.
Pregabalin Zentiva 300 mg hard capsules
Each hard capsule contains 300 mg of pregabalin.
Excipient with known effect
Each hard capsule also contains 30 mg lactose monohydrate.
For the full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Hard capsules
Pregabalin Zentiva 25 mg hard capsules
Light grey cap and light grey body; approx. 15,9 mm in length, hard
gela
                                
                                Soma hati kamili
                                
                            

Nyaraka katika lugha zingine

Taarifa za kipeperushi Taarifa za kipeperushi Kibulgaria 19-03-2024
Tabia za bidhaa Tabia za bidhaa Kibulgaria 19-03-2024
Ripoti ya Tathmini ya umma Ripoti ya Tathmini ya umma Kibulgaria 27-07-2015
Taarifa za kipeperushi Taarifa za kipeperushi Kihispania 19-03-2024
Tabia za bidhaa Tabia za bidhaa Kihispania 19-03-2024
Ripoti ya Tathmini ya umma Ripoti ya Tathmini ya umma Kihispania 27-07-2015
Taarifa za kipeperushi Taarifa za kipeperushi Kicheki 19-03-2024
Tabia za bidhaa Tabia za bidhaa Kicheki 19-03-2024
Ripoti ya Tathmini ya umma Ripoti ya Tathmini ya umma Kicheki 27-07-2015
Taarifa za kipeperushi Taarifa za kipeperushi Kidenmaki 19-03-2024
Tabia za bidhaa Tabia za bidhaa Kidenmaki 19-03-2024
Ripoti ya Tathmini ya umma Ripoti ya Tathmini ya umma Kidenmaki 27-07-2015
Taarifa za kipeperushi Taarifa za kipeperushi Kijerumani 19-03-2024
Tabia za bidhaa Tabia za bidhaa Kijerumani 19-03-2024
Ripoti ya Tathmini ya umma Ripoti ya Tathmini ya umma Kijerumani 27-07-2015
Taarifa za kipeperushi Taarifa za kipeperushi Kiestonia 19-03-2024
Tabia za bidhaa Tabia za bidhaa Kiestonia 19-03-2024
Ripoti ya Tathmini ya umma Ripoti ya Tathmini ya umma Kiestonia 27-07-2015
Taarifa za kipeperushi Taarifa za kipeperushi Kigiriki 19-03-2024
Tabia za bidhaa Tabia za bidhaa Kigiriki 19-03-2024
Ripoti ya Tathmini ya umma Ripoti ya Tathmini ya umma Kigiriki 27-07-2015
Taarifa za kipeperushi Taarifa za kipeperushi Kifaransa 19-03-2024
Tabia za bidhaa Tabia za bidhaa Kifaransa 19-03-2024
Ripoti ya Tathmini ya umma Ripoti ya Tathmini ya umma Kifaransa 27-07-2015
Taarifa za kipeperushi Taarifa za kipeperushi Kiitaliano 19-03-2024
Tabia za bidhaa Tabia za bidhaa Kiitaliano 19-03-2024
Ripoti ya Tathmini ya umma Ripoti ya Tathmini ya umma Kiitaliano 27-07-2015
Taarifa za kipeperushi Taarifa za kipeperushi Kilatvia 19-03-2024
Tabia za bidhaa Tabia za bidhaa Kilatvia 19-03-2024
Ripoti ya Tathmini ya umma Ripoti ya Tathmini ya umma Kilatvia 27-07-2015
Taarifa za kipeperushi Taarifa za kipeperushi Kilithuania 19-03-2024
Tabia za bidhaa Tabia za bidhaa Kilithuania 19-03-2024
Ripoti ya Tathmini ya umma Ripoti ya Tathmini ya umma Kilithuania 27-07-2015
Taarifa za kipeperushi Taarifa za kipeperushi Kihungari 19-03-2024
Tabia za bidhaa Tabia za bidhaa Kihungari 19-03-2024
Ripoti ya Tathmini ya umma Ripoti ya Tathmini ya umma Kihungari 27-07-2015
Taarifa za kipeperushi Taarifa za kipeperushi Kimalta 19-03-2024
Tabia za bidhaa Tabia za bidhaa Kimalta 19-03-2024
Ripoti ya Tathmini ya umma Ripoti ya Tathmini ya umma Kimalta 27-07-2015
Taarifa za kipeperushi Taarifa za kipeperushi Kiholanzi 19-03-2024
Tabia za bidhaa Tabia za bidhaa Kiholanzi 19-03-2024
Ripoti ya Tathmini ya umma Ripoti ya Tathmini ya umma Kiholanzi 27-07-2015
Taarifa za kipeperushi Taarifa za kipeperushi Kipolandi 19-03-2024
Tabia za bidhaa Tabia za bidhaa Kipolandi 19-03-2024
Ripoti ya Tathmini ya umma Ripoti ya Tathmini ya umma Kipolandi 27-07-2015
Taarifa za kipeperushi Taarifa za kipeperushi Kireno 19-03-2024
Tabia za bidhaa Tabia za bidhaa Kireno 19-03-2024
Ripoti ya Tathmini ya umma Ripoti ya Tathmini ya umma Kireno 27-07-2015
Taarifa za kipeperushi Taarifa za kipeperushi Kiromania 19-03-2024
Tabia za bidhaa Tabia za bidhaa Kiromania 19-03-2024
Ripoti ya Tathmini ya umma Ripoti ya Tathmini ya umma Kiromania 27-07-2015
Taarifa za kipeperushi Taarifa za kipeperushi Kislovakia 19-03-2024
Tabia za bidhaa Tabia za bidhaa Kislovakia 19-03-2024
Ripoti ya Tathmini ya umma Ripoti ya Tathmini ya umma Kislovakia 27-07-2015
Taarifa za kipeperushi Taarifa za kipeperushi Kislovenia 19-03-2024
Tabia za bidhaa Tabia za bidhaa Kislovenia 19-03-2024
Ripoti ya Tathmini ya umma Ripoti ya Tathmini ya umma Kislovenia 27-07-2015
Taarifa za kipeperushi Taarifa za kipeperushi Kifinlandi 19-03-2024
Tabia za bidhaa Tabia za bidhaa Kifinlandi 19-03-2024
Ripoti ya Tathmini ya umma Ripoti ya Tathmini ya umma Kifinlandi 27-07-2015
Taarifa za kipeperushi Taarifa za kipeperushi Kiswidi 19-03-2024
Tabia za bidhaa Tabia za bidhaa Kiswidi 19-03-2024
Ripoti ya Tathmini ya umma Ripoti ya Tathmini ya umma Kiswidi 27-07-2015
Taarifa za kipeperushi Taarifa za kipeperushi Kinorwe 19-03-2024
Tabia za bidhaa Tabia za bidhaa Kinorwe 19-03-2024
Taarifa za kipeperushi Taarifa za kipeperushi Kiaisilandi 19-03-2024
Tabia za bidhaa Tabia za bidhaa Kiaisilandi 19-03-2024
Taarifa za kipeperushi Taarifa za kipeperushi Kroeshia 19-03-2024
Tabia za bidhaa Tabia za bidhaa Kroeshia 19-03-2024
Ripoti ya Tathmini ya umma Ripoti ya Tathmini ya umma Kroeshia 27-07-2015

Tafuta arifu zinazohusiana na bidhaa hii